A supramolecular hybrid nanozyme cascade delivery system and its preparation method and application
By constructing a supramolecular hybrid nanoenzyme cascade delivery system of plasmon nanoenzyme substrate Au@Ce and water-soluble macrocyclic aromatic hydrocarbon WLP6, the problems of limited catalytic activity of nanoenzymes and limited penetration of phototherapy tissue are solved, and the problem of limited tissue penetration of nanoenzymes is achieved. Multimodal antibacterial under photoacoustic imaging and promoting wound healing provide experimental basis and theoretical guidance for the development of a visual antibacterial platform.
Patent Information
- Application Number
- CN202411205212.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-30
AI Technical Summary
Existing nanoenzymes have problems of limited catalytic activity and single function in coping with the complex and variable treatment needs of infected wounds, and the near-infrared-II window phototherapy has problems of limited tissue penetration and low skin tolerance threshold.
By constructing a supramolecular hybrid nanoenzyme cascade delivery system of plasmon nanoenzyme substrate Au@Ce and water-soluble macrocyclic aromatic hydrocarbon WLP6, remote activation of multimodal combined treatment is achieved using NIR-II photoacoustic imaging. This system significantly improves catalytic activity through plasmon effect, physical damage to CeO2 at sharp edges and photothermal effects of AuNBPs synergistically eliminate bacteria, and oxidizes L-Arg through ROS cascade to generate NO, achieving oxidation and killing bacteria and clearing biofilms.
Multimodal antibacterial under the guidance of photoacoustic imaging and promoting wound healing are achieved, providing experimental basis and theoretical guidance for the development of a visual antibacterial platform. The system significantly improves antibacterial efficiency and enables accurate indication and real-time monitoring through NIR-II remotely activated photoacoustic imaging.
Smart Images

Figure CN118697871B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedicine technology, and in particular relates to a supramolecular hybrid nanozyme cascade delivery system and a preparation method and application thereof. Background Art
[0002] Bacterial infection is one of the most common wound complications and has become a common problem faced by health care institutions around the world. Antibiotics are currently the main method for clinical treatment of infected wounds, but excessive use of antibiotics can lead to bacterial resistance, accelerating the human entry into the "post-antibiotic" era where no drugs are available. In recent years, nanomedicines have played an increasingly important role in antibacterial treatment. Among them, nanozymes have the advantages of convenient preparation, controllable particle size, high stability, low cost, easy large-scale production, and low resistance to bacterial resistance, and have become an emerging hotspot for the development of antibacterial platforms. However, since the catalytic activity types and rates of most nanozymes are affected by inherent physical and chemical properties and external factors, there are still great limitations in responding to the complex and changeable treatment needs of infected wounds. Therefore, there is an urgent need to develop preparation strategies for highly active nanozymes for the construction of multifunctional antibacterial platforms.
[0003] The synergistic antibacterial strategy based on near-infrared (NIR) phototherapy provides a new direction for the construction of remotely activated nanozyme combined therapy platforms. However, with the continuous deepening of phototherapy research, the limitations of the limited tissue penetration and low skin tolerance threshold of the NIR-I window (650~950 nm) have become increasingly prominent. In contrast, lasers in the NIR-II window (1000~1350 nm) have deeper tissue penetration and higher allowable exposure thresholds. In addition, NIR-II photoacoustic imaging has the characteristics of deep tissue penetration, low background signal, and high spatiotemporal resolution, which has attracted increasing attention in biological therapy and imaging. However, the construction of a nanoplatform integrating NIR-II imaging and therapy is still one of the current challenging and urgently needed research areas. Macrocyclic aromatic hydrocarbons have unique structures, flexible and diverse substituent groups, rich host-guest complexing capabilities, and dynamic and modular assembly characteristics. They can load, encapsulate or covalently couple antibacterial units, making them one of the best candidate units for constructing multifunctional supramolecular hybrid nanoantibacterial agents. However, it still faces the problems of single function and low efficacy. Therefore, it is urgent to develop an organic-inorganic hybrid nanozyme cascade delivery system based on macrocyclic aromatic hydrocarbon molecules. Summary of the invention
[0004] The purpose of the present invention is to provide a supramolecular hybrid nanozyme cascade delivery system and a preparation method and application thereof, aiming to solve the problems raised in the above-mentioned background technology.
[0005] To achieve the above object, the present invention provides the following technical solutions:
[0006] A method for preparing a supramolecular hybrid nanozyme cascade delivery system comprises the following steps:
[0007] Construct a plasmonic material library and a database of multivalent transition metal oxides and sulfides; use plasmonic materials and multivalent transition metal oxides and sulfides to construct plasmonic nanozyme substrates; use water-soluble macrocyclic aromatic hydrocarbons to construct a supramolecular hybrid nanozyme cascade delivery system.
[0008] Furthermore, the plasmon material uses AuNBPs, the multivalent transition metal oxide uses CeO2, and the water-soluble macrocyclic aromatic hydrocarbon uses WLP6. The specific preparation steps are as follows:
[0009] Step 1: selectively grow CeO2 on the surface of AuNBPs by an in-situ growth method to prepare the NIR-II plasmonic nanozyme substrate Au@Ce;
[0010] Step 2: synthesize the fully carboxyl-functionalized water-soluble diagonal aromatic hydrocarbon WLP6, utilize the coordination effect and host-guest modification of WLP6 to load L-Arg through complexation, and construct the supramolecular hybrid nanozyme cascade delivery system ACWL.
[0011] Furthermore, the specific operation of step 1 is: dispersing AuNBPs in 50.0 μM, 4.0 mL of CTAB solution and adding 100.0 μM Ce(Ac)3•6H2O, growing at 100 °C for 1 h, obtaining Au@Ce by centrifugal washing, and dispersing the Au@Ce core-shell structure in H2O.
[0012] Furthermore, in step 1, the aspect ratio of AuNRs and the coverage and thickness of the CeO2 half shell are adjusted so that the Au@Ce surface plasmon resonance absorption peak is located in the NIR-II region, thereby achieving the controllable maximum absorption peak of Au@Ce in the range of 650~1064 nm.
[0013] Furthermore, the specific operation of step 2 is as follows: first, in 1×10 -8 10 mM, 1.0 mL of WLP6 solution was added to 3.0 mL of Au@Ce hydrosol, and the mixture was shaken at room temperature for 24 h, then centrifuged and the supernatant was removed, and the free WLP6 molecules in the system were washed with deionized water; then 10 mM, 0.5 mL of L-Arg was added, and the mixture was shaken at room temperature for 24 h, then centrifuged and the supernatant was removed, and the free L-Arg in the system was washed with deionized water; finally, the material was dispersed in 3.0 mL of deionized water and stored at 4 ℃ for later use.
[0014] A supramolecular hybrid nanozyme cascade delivery system prepared according to the preparation method described above.
[0015] An application of the supramolecular hybrid nanozyme cascade delivery system described above in the preparation of a product that promotes wound healing.
[0016] Compared with the prior art, the present invention has the following beneficial effects:
[0017] 1. The present invention prepares the plasmonic nanozyme substrate Au@Ce through a simple in situ growth method, and constructs a supramolecular hybrid nanozyme cascade delivery system using the modification and complexation of macrocyclic aromatic hydrocarbons, which is used for multimodal antibacterial and wound healing under the guidance of photoacoustic imaging, providing experimental basis and theoretical guidance for the development of a visualized antibacterial platform.
[0018] 2. The present invention achieves multi-mode synergistic destruction of bacteria and biofilms by constructing NIR-II plasmon supramolecular nanozymes. The plasmon effect significantly improves enzyme-like activity, accelerates the catalytic degradation of H2O2 with high expression levels in infected wounds, and continuously produces ROS in situ for oxidative antibacterial and inflammation relief; the sharp edge physical damage of CeO2 and the photothermal effect of AuNBPs synergistically eliminate bacteria and stimulate tissue regeneration. The cascade reaction supramolecular delivery system is constructed to achieve remote activation of multi-mode combined therapy. With the help of ROS cascade oxidation of L-Arg, NO and , through ROS and Dual oxidation kills bacteria and removes biofilms; the photothermal effect of remote activation of the NIR-II window enhances antibacterial efficiency. Photoacoustic imaging remotely activated by NIR-II achieves precise indications, monitors the degree of infection and healing process in real time, and provides conditions for personalized precision treatment. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 It is a schematic diagram of the preparation route of the present invention.
[0020] Figure 2 This is a visualized combined therapy principle diagram of the supramolecular hybrid nanozyme cascade delivery system of the present invention.
[0021] Figure 3 It is the isotropic material library of the present invention.
[0022] Figure 4 It is a representative plasmonic nanozyme substrate in the present invention; wherein, A is a CeO2 shell layer grown on the surface of AuNBPs (Au@Ce); B is a CeO2 shell layer grown on the two tips of AuNBPs (Au-tCe); C is a CeO2 shell layer grown on the surface of gold nanorods (AuNRs) (AuNR@Ce); and D is a CeO2 shell layer grown on the surface of gold nanocups (Aucups) (Aucup@Ce).
[0023] Figure 5is the antibacterial activity of the supramolecular hybrid nanozyme cascade delivery system of the present invention; wherein A is the antibacterial activity study of ACWL against Gram-negative bacteria Escherichia coli (E. coli) under different media conditions; B is Figure 5 The survival rate of E. coli in each group in part A; C is the study of the antibacterial activity of ACWL against Gram-positive bacteria methicillin-resistant Staphylococcus aureus (MRSA) under different media conditions; D is Figure 5 Part C shows the survival rate of MRSA in each group.
[0024] Figure 6 It is the biosafety of the supramolecular hybrid nanozyme cascade delivery system of the present invention and its combined therapeutic performance on infected wounds; wherein, A is the MTT test of a series of concentrations of ACWL on L929 cells; B is the study of the combined therapeutic performance of ACWL on subcutaneous abscesses infected with MRSA. DETAILED DESCRIPTION
[0025] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0026] The specific implementation of the present invention is described in detail below in conjunction with specific embodiments.
[0027] Example 1: A method for preparing a supramolecular hybrid nanozyme cascade delivery system provided in one embodiment of the present invention comprises the following steps:
[0028] A plasmonic material library and a database of multivalent transition metal oxides and sulfides were constructed respectively; a series of plasmonic nanozyme substrates were constructed using the orthogonal combination method; and a supramolecular hybrid nanozyme cascade delivery system was constructed using water-soluble macrocyclic aromatic hydrocarbons.
[0029] In an embodiment of the present invention, the plasmon effect is utilized to precisely control the wavelength of the localized surface plasmon resonance absorption peak, thereby significantly improving the catalytic activity of the hybrid nanozyme and realizing remotely activated visualized combined therapy. Based on the modification and complexation of macrocyclic aromatic hydrocarbons, a stimulus-responsive supramolecular delivery system is constructed, providing a simple and efficient method for developing a visualized antibacterial platform.
[0030] Plasmon material library: including single metal gold nanorods / balls / stars / cups / triangles / bipyramids, etc., silver nanospheres / rods / wires; alloys or assembly structures of binary or higher metals (such as core-shell, asymmetric growth, etc.), such as silver-coated gold nanorods, in-situ platinum deposition on both ends of gold rods, etc.; new plasmon materials, such as Ti3C2, Mo2C, Nb2C, etc. ( Figure 3 ).
[0031] Multivalent transition metal library: Bi, Mn, Fe, Co, Ni, Cu, Ce, Ti, In, Ga, etc.
[0032] Macrocyclic aromatic hydrocarbon molecular library: The skeleton includes cucurbituril, cyclodextrin, calixarene, columnar aromatics and diagonal aromatics; the substituent groups include carboxylate, sulfonate and amino groups that can coordinate with metals, as well as quaternary ammonium salts and phosphates that can be modified on the surface of materials through electrostatic effects.
[0033] As a preferred embodiment of the present invention, by regulating the Ce(III) concentration, temperature and growth time, the growth site, thickness and edge structure of CeO2 on the surface of AuNBPs can be precisely controlled. Among them, the three most typical structures are the growth of CeO2 shell (Au@Ce) on the surface of AuNBPs, the growth of CeO2 at the two tips of AuNBPs (Au-tCe), and the growth of CeO2 at both ends and in the middle of AuNBPs (Au-iCe). By utilizing the different deposition amounts and deposition sites of CeO2 in these three structures, the absorption wavelength of the material to NIR laser and its physical and chemical properties such as enzyme-like catalytic activity can be adjusted.
[0034] Plasmonic materials and multivalent transition metal oxides are exemplified by gold nanobipyramids (AuNBPs) and cerium dioxide (CeO2), respectively, and water-soluble macrocyclic aromatic hydrocarbons are exemplified by fully carboxyl-substituted diagonal aromatic hydrocarbons (WLP6). The specific steps for constructing the supramolecular hybrid nanozyme cascade delivery system are as follows ( Figure 1 )as follows:
[0035] First, Ce(Ac)3•6H2O provides Ce 3+ , a one-step reduction method with mild conditions and simple operation was used to selectively grow a jagged CeO2 shell on the surface of AuNBPs to prepare the NIR-II plasmonic nanozyme substrate Au@Ce. This method is applicable to a variety of other Au materials with different morphologies and sizes ( Figure 4 ).
[0036] Secondly, the fully carboxyl-substituted tilted aromatic hydrocarbon WLP6 was synthesized, and the carboxylate substituent group was coordinated with CeO2 to prepare the WLP6-functionalized supramolecular hybrid nanozyme through a one-step ligand exchange method; the active nitrogen source L-Arg was loaded with the help of the host-guest interaction of WLP6 to construct the supramolecular hybrid nanozyme cascade delivery system ACWL, which provided experimental basis and theoretical guidance for the development of a visualized combined antibacterial platform.
[0037] In the embodiment of the present invention, the activity of the enzyme is significantly improved by the plasmon effect, the catalytic degradation of the highly expressed H2O2 in the infected wound site is accelerated, and ROS is continuously generated in situ for oxidative antibacterial and inflammation relief; the physical damage of the sharp edge of CeO2 and the photothermal effect of AuNBPs are used to synergistically eliminate bacteria and stimulate tissue regeneration. The remote activation multi-modal combined therapy is achieved by constructing a supramolecular delivery system with cascade reactions. With the help of ROS cascade oxidation of L-Arg, NO and , through ROS and Dual oxidation kills bacteria and removes biofilm ( Figure 2 ).
[0038] Example 2: Developing a general preparation strategy for plasmonic nanozyme substrates;
[0039] AuNBPs were dispersed in CTAB solution (50.0 μM, 4.0 mL), and Ce(Ac)3•6H2O was added to provide Ce 3+ (100.0μM), at 100 °C, and allowed to grow for 1 h. After centrifugation and washing, the Au@Ce core-shell structure was dispersed in H2O. By adjusting the aspect ratio of AuNBPs and the coverage and thickness of the CeO2 half shell, the maximum absorption peak of Au@Ce was precisely controllable in the range of 650~1064 nm. This method has been shown to have good applicability and high repeatability for a variety of plasmonic substrates such as gold nanorods and gold nanocups, providing a general preparation strategy for constructing plasmonic nanozyme substrates.
[0040] Example 3: Construction of a visual antibacterial platform based on supramolecular plasmon nanozymes;
[0041] Taking the Au@Ce plasmon nanozyme with a core-shell structure in Example 2 as the substrate and the water-soluble diagonal aromatic hydrocarbon WLP6 as an example, a supramolecular hybrid nanozyme cascade delivery system was constructed:
[0042] First, in Au@Ce hydrosol (1×10 -8 M, 3.0 mL) was added with WLP6 solution (10 mM, 1.0 mL) and shaken at room temperature for 24 h. Centrifuge, remove the supernatant, and wash the free WLP6 molecules in the system with deionized water. Then, add the active nitrogen source L-arginine (L-Arg, 10 mM, 0.5 mL) and shaken at room temperature for 24 h. Centrifuge, remove the supernatant, and wash the free L-Arg in the system with deionized water. Finally, the material was dispersed in deionized water (3.0 mL) and stored at 4 °C for use.
[0043] Example 4. Antibacterial activity of supramolecular hybrid nanozyme cascade delivery system;
[0044] Colony experiments and statistical analysis showed that the material showed high inhibitory ability against both Gram-negative bacteria Escherichia coli (E. coli) and Gram-positive bacteria methicillin-resistant Staphylococcus aureus (MRSA) ( Figure 5 ). Figure 5 A is a comparative analysis of the colony growth of E. coli after pretreatment with PBS, PBS+L (L means 1064 nm laser irradiation treatment), ACWL and ACWL+L. Figure 5 Figure B shows the statistical results of the survival rate of E. coli in each group, with the PBS-treated group as the blank control. Figure 5 Figure C shows the colony growth after MRSA was pretreated using the same conditions and methods. Figure 5 D is the statistical result of MRSA survival rate in each group, with PBS treatment group as blank control. The above results show that ACWL within the safe dose range can completely kill Gram-negative bacteria E. coli and Gram-positive bacteria MRSA under 1064 nm laser radiation.
[0045] Example 5: Study the biosafety of the ACWL system and its combined therapeutic performance on infected wounds;
[0046] like Figure 6 In Figure A, the biosafety of the ACWL system was studied using the L928 cell model through the MTT test to ensure that the delivery system meets the basic safety requirements for wound treatment. The results showed that the survival rate of L928 cells was above 95% when the ACWL concentration ranged from 0 to 200 μg / mL, indicating that ACWL has good biosafety.
[0047] like Figure 6 In the middle B, MRSA was used as the model strain, and a mouse subcutaneous abscess model was constructed by subcutaneous injection. The principle of controlled variables was strictly followed, and four groups were set up: PBS, PBS+L, ACWL, and ACWL+L. The abscess site was pretreated, and the treatment process of the abscess site was regularly and continuously monitored and recorded. The results showed that on the 12th day, the abscess site in the ACWL+L experimental group was almost eliminated, and the healing process was significantly faster than that of the other three control groups, proving that under 1064 nm laser radiation, ACWL within the safe dose range has significant combined therapeutic performance for MRSA-infected subcutaneous abscesses ( Figure 6 The above experiments can provide feedback to guide the screening and formulation of efficient and safe treatment plans ( Figure 2 ), providing experimental and theoretical basis for developing new antibacterial platforms and realizing visualized combined treatment of infected wounds.
[0048] The above are only preferred embodiments of the present invention. It should be pointed out that, for those skilled in the art, several modifications and improvements can be made without departing from the concept of the present invention. These should also be regarded as the protection scope of the present invention. These will not affect the effect of the implementation of the present invention and the practicality of the patent.
Claims
1. A method for preparing a supramolecular hybrid nanozyme cascade delivery system, characterized in that: The following steps are involved: Construct a library of plasmonic materials and a database of multivalent transition metal oxides and sulfides; construct plasmonic nanozyme substrates using plasmonic materials and multivalent transition metal oxides and sulfides; construct a supramolecular hybrid nanozyme cascade delivery system using water-soluble macrocyclic aromatic hydrocarbons; The plasmon material is AuNBPs, the multivalent transition metal oxide is CeO2, and the water-soluble macrocyclic aromatic hydrocarbon is WLP6. The specific preparation steps are as follows: Step 1: selectively grow CeO2 on the surface of AuNBPs by an in-situ growth method to prepare the NIR-II plasmonic nanozyme substrate Au@Ce; Step 2: synthesize the fully carboxyl-functionalized water-soluble diagonal aromatic hydrocarbon WLP6, utilize the coordination effect and host-guest modification of WLP6 to load L-Arg through complexation, and construct the supramolecular hybrid nanozyme cascade delivery system ACWL; The specific operation of step 1 is: disperse AuNBPs in 50.0 μM, 4.0 mL CTAB solution and add 100.0 μM Ce(Ac)3•6H2O, let it stand for 1 h at 100 °C, obtain Au@Ce by centrifugal washing, and disperse the Au@Ce core-shell structure in H2O; In the step 1, the aspect ratio of AuNBPs and the coverage and thickness of the CeO2 half shell are adjusted so that the surface plasmon resonance absorption peak of Au@Ce is located in the NIR-II region, so that the maximum absorption peak of Au@Ce can be controlled at 650~1064 nm; The specific operation of step 2 is: first, in 1×10 -8 10 mM, 1.0 mL of WLP6 solution was added to 3.0 mL of Au@Ce hydrosol, and the mixture was shaken at room temperature for 24 h, then centrifuged and the supernatant was removed, and the free WLP6 molecules in the system were washed with deionized water; then 10 mM, 0.5 mL of L-Arg was added, and the mixture was shaken at room temperature for 24 h, then centrifuged and the supernatant was removed, and the free L-Arg in the system was washed with deionized water; finally, the material was dispersed in 3.0 mL of deionized water and stored at 4 °C for later use.
2. A supramolecular hybrid nanozyme cascade delivery system prepared according to the preparation method according to claim 1.
3. Use of the supramolecular hybrid nanozyme cascade delivery system according to claim 2 in the preparation of products that promote wound healing.
Citation Information
Patent Citations
Preparation method of gold-silver core-shell nano bipyramid-cerium dioxide composite material
CN115400753A
Multifunctional cascade nano-enzyme as well as preparation method and application thereof
CN115888773A
Preparation method and application of supramolecular nanomaterial with photodynamic-photothermal synergistic antibacterial activity
CN116712544A
Hollow mesoporous monatomic molybdenum nano-enzyme and preparation method thereof as well as preparation and application of nano-enzyme reactor based on hollow mesoporous monatomic molybdenum nano-enzyme
CN116851741A
KR20210117020A
